These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2143745)

  • 21. Luteinizing hormone-releasing hormone receptor-targeted chemotherapy using AN-152.
    Emons G; Sindermann H; Engel J; Schally AV; Gründker C
    Neuroendocrinology; 2009; 90(1):15-8. PubMed ID: 19521066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
    Debruyne FM; Karthaus HF; Schröder FH; de Voogt HJ; de Jong FH; Klijn JG
    Prog Clin Biol Res; 1985; 185A():251-70. PubMed ID: 3929265
    [No Abstract]   [Full Text] [Related]  

  • 23. [What is safe in the therapy of advanced prostatic cancer?].
    Gropp C; Burk K
    Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of goserelin in the treatment of breast cancer.
    Rody A; Loibl S; von Minckwitz G; Kaufmann M
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):591-604. PubMed ID: 16111461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.
    Kaisary AV; Ryan PG; Turkes A; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1988; 260():89-100. PubMed ID: 2966408
    [No Abstract]   [Full Text] [Related]  

  • 26. New endocrine approaches to breast cancer.
    Howell A; Dodwell DJ; Anderson H
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):67-84. PubMed ID: 1975167
    [No Abstract]   [Full Text] [Related]  

  • 27. [A case of a premenopausal woman with advanced breast cancer treated with aromatization inhibition in combination with luteinizing hormone-releasing hormone agonist].
    Hisamatsu K; Iwamori S; Minami K; Tanabe K; Ota K; Akiyama H
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1327-30. PubMed ID: 9279354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancer.
    Furr BJ; Nicholson RI
    J Reprod Fertil; 1982 Mar; 64(2):529-39. PubMed ID: 6461763
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pituitary gonadotropin releasing hormone (GnRH) and breast cancer].
    Vargas Hernández VM; Moctezuma Espinosa J
    Ginecol Obstet Mex; 1995 Dec; 63():493-6. PubMed ID: 8586292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report].
    Asaga S; Ando J; Arai T; Fujii H
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1069-72. PubMed ID: 16044976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer.
    Nicholson RI; Walker KJ; Walker RF; Read GF; Turkes A; Robertson JF; Blamey RW
    Horm Res; 1989; 32 Suppl 1():198-201. PubMed ID: 2533149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New treatment for prostatic cancer.
    Lancet; 1983 Aug; 2(8347):438. PubMed ID: 6135918
    [No Abstract]   [Full Text] [Related]  

  • 33. Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects.
    Nicholson RI; Walker KJ; Bouzubar N; Wills RJ; Gee JM; Rushmere NK; Davies P
    Ann N Y Acad Sci; 1990; 595():316-27. PubMed ID: 2142873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gn-RH agonists in breast and gynaecologic cancer treatment.
    Nicholson RI; Walker KJ
    J Steroid Biochem; 1989 Oct; 33(4B):801-4. PubMed ID: 2532269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotrophin hormone releasing analogues open new doors in cancer treatment.
    Waxman J
    Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1084-5. PubMed ID: 2961401
    [No Abstract]   [Full Text] [Related]  

  • 36. [Report of the International Symposium on "Zoladex--the new therapy concept in breast cancer" Cambridge, 9-11 September 1990].
    Zentralbl Gynakol; 1991; 113(6):333-8. PubMed ID: 1829309
    [No Abstract]   [Full Text] [Related]  

  • 37. [LH-RH analogs in mammary carcinoma: experimental aspects].
    Scambia G; Benedetti Panici P; De Vincenzo R; Isola G; Mancuso S
    Drugs Exp Clin Res; 1990; 16 Suppl():39-46. PubMed ID: 2081450
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy.
    Poggio F; Conte B; Lambertini M
    Breast Cancer Res Treat; 2018 Aug; 171(1):245-246. PubMed ID: 29744675
    [No Abstract]   [Full Text] [Related]  

  • 39. Will gonadotrophin releasing hormone analogues profoundly affect gynaecological practice?
    Pepperell RJ
    Aust N Z J Obstet Gynaecol; 1985 Nov; 25(4):285-8. PubMed ID: 3938950
    [No Abstract]   [Full Text] [Related]  

  • 40. Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery.
    Vercellini P; Ferrari A; D'Alberton A; Motta T; Maggi R; Molteni P
    Eur J Obstet Gynecol Reprod Biol; 1992 Jun; 45(1):70-2. PubMed ID: 1535604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.